Urinary apolipoprotein AI in children with kidney disease-Reference-Cited by-同舟云学术

Urinary apolipoprotein AI in children with kidney disease

Published:2019-06-23 Issue:11 Volume:34 Page:2351-2360
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Clark Amanda J.^ORCID,Jabs Kathy,Hunley Tracy E.,Jones Deborah P.,VanDeVoorde Rene G.,Anderson Carl,Du Liping,Zhong Jianyong,Fogo Agnes B.,Yang Haichun,Kon Valentina

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-019-04289-5.pdf

Reference36 articles.

1. Khera AV, Demler OV, Adelman SJ, Collins HL, Glynn RJ, Ridker PM, Rader DJ, Mora S (2007) Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating Rosuvastatin). Circulation 135:2494–2504

2. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW (2014) HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 371:2383–2393

3. Zhou L, Li C, Gao L, Wang A (2015) High-density lipoprotein synthesis and metabolism (review). Mol Med Rep 12:4015–4021

4. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000

5. Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiating primary and secondary FSGS using non-invasive urine biomarkers;Clinical Kidney Journal;2023-12-04

2. Comparisons of beta2-microglobulin, apolipoprotein A1, and immunoglobulins (IgG and IgM) detected in the serum and urine from individual cats;Austral Journal of Veterinary Sciences;2023-10-26

3. Urinary Apolipoprotein A1 and Neutrophil Gelatinase-associated Lipocalin in Children with Idiopathic Nephrotic Syndrome;Saudi Journal of Kidney Diseases and Transplantation;2023

4. Urinary proteome of dogs with renal disease secondary to leishmaniosis;Research in Veterinary Science;2022-12

5. Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury;JCI Insight;2022-11-08